Targeting cytokine and chemokine signaling pathways for cancer therapy

M Yi, T Li, M Niu, H Zhang, Y Wu, K Wu… - Signal transduction and …, 2024 - nature.com
Cytokines are critical in regulating immune responses and cellular behavior, playing dual
roles in both normal physiology and the pathology of diseases such as cancer. These …

Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms

Y Wu, X Sun, K Kang, Y Yang, H Li, A Zhao… - Journal of Hematology & …, 2024 - Springer
Hemophagocytic lymphohistiocytosis (HLH) is a rapidly progressing, life-threatening
syndrome characterized by excessive immune activation, often presenting as a complex …

Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial

MJ Mooradian, FJ Fintelmann, TJ LaSalle… - Nature …, 2024 - nature.com
Image-guided percutaneous cryoablation is an established minimally invasive oncologic
treatment. We hypothesized that cryoablation may modify the immune microenvironment …

Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma

H Yan, A Jiang, Y Huang, J Zhang, W Yang… - Frontiers in …, 2023 - frontiersin.org
Introduction Hypoxia is associated with unfavorable prognoses in melanoma patients, and
the limited response rates of patients to PD-1/PD-L1 blockade could be attributed to the …

Interferon signaling and ferroptosis in tumor immunology and therapy

W Hu, Z Zhao, J Du, J Jiang, M Yang, M Tian… - NPJ Precision …, 2024 - nature.com
This study sought to elucidate the mechanisms underlying the impact of the interferon
signaling pathway on Ferroptosis in tumor cells and its correlation with CD8+ T cell …

Lynch syndrome-associated and sporadic microsatellite unstable colorectal cancers: different patterns of clonal evolution yield highly similar tumours

S Martin, R Katainen, A Taira, N Välimäki… - Human Molecular …, 2024 - academic.oup.com
Microsatellite unstable colorectal cancer (MSI-CRC) can arise through germline mutations in
mismatch repair (MMR) genes in individuals with Lynch syndrome (LS), or sporadically …

Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets

Z Hong, F Liu, Z Zhang - Experimental Hematology & Oncology, 2024 - Springer
Although immune checkpoint-based cancer immunotherapy has shown significant efficacy
in various cancers, resistance still limits its therapeutic effects. Ubiquitination modification is …

Silver nanoparticle induced immunogenic cell death can improve immunotherapy

A Sargsian, X Koutsoumpou, H Girmatsion… - Journal of …, 2024 - Springer
Cancer immunotherapy is often hindered by an immunosuppressive tumor
microenvironment (TME). Various strategies are being evaluated to shift the TME from an …

Research progress and prospect of tumor nanovaccine combination therapy strategy

Y Yin, J Guo, S Zhang, M Xu, Y Fu, M Zhang… - Chinese Chemical …, 2024 - Elsevier
Cancer remains one of the major threats to public health. Traditional chemotherapy,
radiotherapy, and other anti-tumor therapies have numerous limitations in clinical treatment …

Roles of Interferon Regulatory Factor 1 in Tumor Progression and Regression: Two Sides of a Coin

AM Perevalova, LF Gulyaeva… - International Journal of …, 2024 - mdpi.com
IRF1 is a transcription factor well known for its role in IFN signaling. Although IRF1 was
initially identified for its involvement in inflammatory processes, there is now evidence that it …